Artixio

End to End Regulatory Partner in the USA

Strategy to Product Launch and Post Market, Ensuring Compliance Through the Lifesciences Products Lifecycle
The United States of America is key markets for global manufacturers and brands across industries. The massive Pharmaceutical, Medical Devices, Nutraceutical and Cosmetics industry with market size of approx. USD 600 Billion, 300 Billion, 85 Billion and 67 Billion respectively, enables lifesaving, health and wellness innovations to thrive in the country while benefitting end users. With a highly regulated industry led by the Food and Drug Administration (US FDA), every product must go through a stringent evaluation pathway to ensure efficacy and safety of the products for human and animal use.

Artixio, with its team’s decades of experience in successfully registering and post market compliance maintenance for diverse lifesciences products across regulatory affairs, quality (GxP), market access in the USA.

Regulatory Authorities in the USA

Key bodies within FDA that regulate various lifesciences products include, Center for Devices and Radiological Health (CDRH) that Regulates companies that manufacture, import or market medical devices in the USA; Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) that is responsible for review and regulation of biopharmaceutical products; Center for Food Safety and Applied Nutrition (CFSAN) and Center for Veterinary Medicine

Pre-Registration

Registration services

Post-Registration

Our Services

Regulatory Affairs
Product Registration
Market Access
IND (Investigational New Drug)
NDA (New Drug Application)
Regulatory Operations
Technical Writing
Regulatory Strategy
Market Access

Why Artixio?

Successful Approvals and Ongoing Product Lifecycle Maintenance for 200+ Products
Diverse Experience across Complex Products Categories and Therapeutic Areas
Strong Regional Expertise, Experts with 15-35 years of experience
End-to-End Partner Concept to Market & Post Market
Proven Experience in Navigating through Complex, often Ambiguous Regulations
Intelligence driven, global regulatory services supported by QuriousRI
ISO 9001:2015 quality standards governed services.
Customer focused, flexible services and solutions.
Flexible Business Model including project based, managed services and FTE staffing model.
Hybrid-Local-Centralized Support across Regulatory functions.

Industries We Serve in the USA

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

FAQs

What are different submissions that you support in the USA?
Artixio supports submissions for products across pharmaceutical, biological, medical devices, diagnostics, cosmetics, nutraceuticals, veterinary, animal feed and related industries. The submissions include IND, NDA, ANDA, BLA, 510(k), PMA, De Novo Requests, NDI notifications, Cosmetic Facility Registrations, MoCRA, INAD, NADA and others.
Yes, Artixio supports international manufacturers by acting as their US Agent representing them to the FDA, managing communication, audit support, response to queries and coordinate submission/post submission activities.
We support post approval maintenance activities such as change/variations management, CMC change management, artwork and labelling change management, advertisement and promotional material review, SPL filing, renewals, annual reports ongoing regulatory intelligence and monitoring.
We support right from Quality Management System (QMS) development, implementation and training, Standard Operating Procedures authoring, harmonization, support with mock audits and vendor audits across GMP, GCP, GPVP, GDP and other areas. Our compliance team is seasoned to guide through 21 CFR Part 210/211, 820, 600, 111, ISO 13485, 22716 for different product types.

Our Global Reach: Serving Life
Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

Europe

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

May 2, 2025
UK Releases Amendment & Guidance on Regulations in 2024 for Medical Devices (Post-market Surveillance Requirements)

UK Releases Amendment &

In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

April 23, 2025
Artixio Announces Grant for Early Stage Medtech Innovators as Part of MedTech InnovateIO Initiative

Artixio Announces Grant for

HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...

April 16, 2025